e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Cell biology and murine models of asthma and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LPS induced inflammation depends on particles size
V. Doyen, G. Pilcer, D. Phong, F. Corazza, L. Vanderschaele, P. Bergmann, K. Amighi, O. Michel (Brussels, Belgium; Ho Chi Minh City, Viet Nam)
Source:
Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Session:
Cell biology and murine models of asthma and inflammation
Session type:
Thematic Poster Session
Number:
881
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Doyen, G. Pilcer, D. Phong, F. Corazza, L. Vanderschaele, P. Bergmann, K. Amighi, O. Michel (Brussels, Belgium; Ho Chi Minh City, Viet Nam). LPS induced inflammation depends on particles size. Eur Respir J 2013; 42: Suppl. 57, 881
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Effects of anti-IL17 on inflammation, remodeling, and oxidative stress in an experimental model of asthma exacerbated by LPS
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Effect of human neutrophil proteases on
ex vivo
small airway function
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Effect of photobiomodulation on inflammation and production of TGF-ß in experimental model of pulmonary fibrosis.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Effect of doxofylline on LPS-induced leukocyte migration to the lung
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Effect of low level light therapy (LLLT) on an experimental model of LPS-induced lung inflammation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Cellular approach of salbutamol effects on chronic lung inflammation induced by OVA in murine model
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
Oral presentation: TLR-3 triggered aggravation of experimental asthma depends on IL-17
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Oral presentation: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012
Systemic inflammatory repercussions after pleurodesis in an experimental model of pneumothorax
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013
Short-term respiratory and systemic inflammatory responses to welding exposure
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Chronic LPS instillation model in mice: a useful model for emphysema studies?
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Effects of acute and chronic LPS exposure on the inflammatory response in CF mice
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept